BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hsu PI, Lai KH, Tseng HH, Liu YC, Yen MY, Lin CK, Lo GH, Huang RL, Huang JS, Cheng JS. Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia. J Clin Gastroenterol. 1997;25:587-591. [PMID: 9451668 DOI: 10.1097/00004836-199712000-00007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Serrano CA, González CG, Rollan AR, Duarte I, Torres J, Peña AJ, Harris PR. Lack of Diagnostic Utility of Specific Immunoglobulin M in Helicobacter pylori Infection in Children. Journal of Pediatric Gastroenterology & Nutrition 2008;47:612-7. [DOI: 10.1097/mpg.0b013e3181668648] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Chen A, Li CN, Hsu PI, Lai KH, Tseng HH, Hsu PN, Lo GH, Lo CC, Lin CK, Hwang IR. Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer. Aliment Pharmacol Ther. 2004;20:203-211. [PMID: 15233701 DOI: 10.1111/j.1365-2036.2004.01826.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.1] [Reference Citation Analysis]
3 Hsu PI, Wu DC, Wu JY, Graham DY. Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days? Helicobacter. 2011;16:146-152. [PMID: 21435093 DOI: 10.1111/j.1523-5378.2011.00829.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 47] [Article Influence: 3.5] [Reference Citation Analysis]
4 Lin CK, Hsu PI, Lai KH, Lo GH, Tseng HH, Lo CC, Peng NJ, Chen HC, Jou HS, Huang WK, Chen JL, Hsu PN. One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy. J Clin Gastroenterol 2002;34:547-51. [PMID: 11960067 DOI: 10.1097/00004836-200205000-00013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
5 Hsu PI, Jwo JJ, Tseng HH, Lai KH, Lo GH, Lo CC, Wu CJ, Chuah SK, Hwang IR, Chen JL, Chen YS, Chen A. Association of the myeloperoxidase-468G→A polymorphism with gastric inflammation and duodenal ulcer risk. World J Gastroenterol 2005; 11(18): 2796-2801 [PMID: 15884126 DOI: 10.3748/wjg.v11.i18.2796] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Lo C, Hsu P, Lo G, Lai K, Cheng J, Tseng H, Lin C, Chan H, Wang Y, Ku M, Lin C, Peng N, Chien EJ. Comparison of clinical, serological and histological findings between non‐ulcer dyspepsia patients with and without Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 2001;16:276-81. [DOI: 10.1046/j.1440-1746.2001.02417.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
7 Gong YH, Sun LP, Jin SG, Yuan Y. Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7,241 subjects from China. Eur J Clin Microbiol Infect Dis. 2010;29:907-911. [PMID: 20440530 DOI: 10.1007/s10096-010-0944-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
8 Hsu PI, Lai KH, Tseng HH, Lin CK, Lo GH, Cheng JS, Chan HH, Chen GC, Jou HS, Peng NJ. Risk factors for presentation with bleeding in patients with Helicobacter pylori-related peptic ulcer diseases. J Clin Gastroenterol. 2000;30:386-391. [PMID: 10875466 DOI: 10.1097/00004836-200006000-00007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
9 Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Yuan Y. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers. Scand J Gastroenterol. 2014;49:259-266. [PMID: 24329006 DOI: 10.3109/00365521.2013.869352] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hsu PI, Li CN, Tseng HH, Lai KH, Hsu PN, Lo GH, Lo CC, Yeh JJ, Ger LP, Hsiao M. The interleukin-1 RN polymorphism and Helicobacter pylori infection in the development of duodenal ulcer. Helicobacter. 2004;9:605-613. [PMID: 15610073 DOI: 10.1111/j.1083-4389.2004.00277.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
11 Hsu PI, Wu DC, Wu JY, Graham DY. Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter. 2011;16:139-145. [PMID: 21435092 DOI: 10.1111/j.1523-5378.2011.00828] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Lee JY, Gong EJ, Chung EJ, Park HW, Bae SE, Kim EH, Kim J, Do YS, Kim TH, Chang HS, Song HJ, Choe J, Jung HY. The Characteristics and Prognosis of Diffuse-Type Early Gastric Cancer Diagnosed during Health Check-Ups. Gut Liver 2017;11:807-12. [PMID: 28798286 DOI: 10.5009/gnl17033] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
13 Klaamas K, Kurtenkov O, Rittenhouse-Olson K, Brjalin V, Miljukhina L, Shljapnikova L, Engstrand L. Expression of tumor-associated Thomsen-Friedenreich antigen (T Ag) in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals. Immunol Invest 2002;31:191-204. [PMID: 12472179 DOI: 10.1081/imm-120016240] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
14 Lo CC, Hsu PI, Lo GH, Lai KH, Tseng HH, Lin CK, Chan HH, Tsai WL, Chen WC, Peng NJ. Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome. World J Gastroenterol 2005; 11(30): 4715-4720 [PMID: 16094716 DOI: 10.3748/wjg.v11.i30.4715] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
15 Rendell-Baker L. Nineteenth-century resuscitation apparatus. Anaesthesia. 1981;36:1058-1059. [PMID: 7032348 DOI: 10.1111/j.1365-2362.2006.01725.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
16 Holmes KP, Fang JC, Jackson BR. Cost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern. BMC Health Serv Res 2010;10:344. [PMID: 21176158 DOI: 10.1186/1472-6963-10-344] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
17 Hsu PI, Lai KH, Lo GH, Tseng HH, Lo CC, Chen HC, Tsai WL, Jou HS, Peng NJ, Chien CH. Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients. Gut. 2002;51:15-20. [PMID: 12077085 DOI: 10.1136/gut.51.1.15] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
18 Seo JH, Lim CW, Park JS, Yeom JS, Lim JY, Jun JS, Woo HO, Youn HS, Baik SC, Lee WK, Cho MJ, Rhee KH. Correlations between the CagA Antigen and Serum Levels of Anti-Helicobacter pylori IgG and IgA in Children. J Korean Med Sci 2016;31:417-22. [PMID: 26955243 DOI: 10.3346/jkms.2016.31.3.417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
19 Tsay FW, Tseng HH, Hsu PI, Wang KM, Lee CC, Chang SN, Wang HM, Yu HC, Chen WC, Peng NJ. Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan. J Gastroenterol Hepatol. 2012;27:498-503. [PMID: 21871025 DOI: 10.1111/j.1440-1746.2011.06885.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
20 Tsai TJ, Lai KH, Hsu PI, Lin CK, Chan HH, Yu HC, Wang HM, Lin KH, Wang KM, Chang SN, Liu CP, Hsiao SH, Huang HR, Lin CH, Tsay FW. Upper gastrointestinal lesions in patients receiving clopidogrel anti-platelet therapy. J Formos Med Assoc. 2012;111:705-710. [PMID: 23265750 DOI: 10.1016/j.jfma.2011.11.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
21 Skinner LJ, Winter DC, Curran AJ, Barnes C, Kennedy S, Maguire AJ, Charles DA, Timon CI, Burns HP. Helicobacter pylori and tonsillectomy. Clin Otolaryngol Allied Sci. 2001;26:505-509. [PMID: 11843933 DOI: 10.1046/j.1365-2273.2001.00513.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
22 Lo CC, Lai KH, Peng NJ, Lo GH, Tseng HH, Lin CK, Shie CB, Wu CM, Chen YS, Huang WK, Chen A, Hsu PI. Polymerase chain reaction: A sensitive method for detecting Helicobacter pylori infection in bleeding peptic ulcers. World J Gastroenterol 2005; 11(25): 3909-3914 [PMID: 15991292 DOI: 10.3748/wjg.v11.i25.3909] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
23 Flores-Luna L, Camorlinga-Ponce M, Hernandez-Suarez G, Kasamatsu E, Martínez ME, Murillo R, Lazcano E, Torres J. The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries. Cancer Causes Control. 2013;24:241-248. [PMID: 23184121 DOI: 10.1007/s10552-012-0106-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
24 Hsu PI, Lai KH, Lin CK, Chen WC, Yu HC, Cheng JS, Tsay FW, Wu CJ, Lo CC, Tseng HH. A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol. 2005;100:2387-2392. [PMID: 16279889 DOI: 10.1111/j.1572-0241.2005.00264.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
25 Kell MR, Winter DC, Ryan D, Lynch M, Brew B, Rajpal P, Kirwan WO, Redmond HP. Nitric oxide synthetase and Helicobacter pylori in patients undergoing appendicectomy. Br J Surg. 1999;86:1538-1542. [PMID: 10632658 DOI: 10.1046/j.1365-2168.1999.01268.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
26 Ogata SK, Kawakami E, Patrício FR, Pedroso MZ, Santos AM. Evaluation of invasive and non-invasive methods for the diagnosis of Helicobacter pylori infection in symptomatic children and adolescents. Sao Paulo Med J 2001;119:67-71. [PMID: 11276169 DOI: 10.1590/s1516-31802001000200006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
27 Hsu PI, Lai KH, Hsu PN, Lo GH, Yu HC, Chen WC, Tsay FW, Lin HC, Tseng HH, Ger LP. Helicobacter pylori infection and the risk of gastric malignancy. Am J Gastroenterol. 2007;102:725-730. [PMID: 17324128 DOI: 10.1111/j.1572-0241.2006.01109.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 4.2] [Reference Citation Analysis]
28 Lu PJ, Hsu PI, Chen CH, Hsiao M, Chang WC, Tseng HH, Lin KH, Chuah SK, Chen HC. Gastric juice acidity in upper gastrointestinal diseases. World J Gastroenterol 2010; 16(43): 5496-5501 [PMID: 21086570 DOI: 10.3748/wjg.v16.i43.5496] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
29 Chen XZ, Huang CZ, Hu WX, Liu Y, Yao XQ. Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening. Chin Med J (Engl). 2018;131:1232-1239. [PMID: 29722342 DOI: 10.4103/0366-6999.231512] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
30 Kao SS, Chen WC, Hsu PI, Lai KH, Yu HC, Cheng HH, Peng NJ, Lin CK, Chan HH, Tsai WL. 7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan. Gastroenterol Res Pract. 2012;2012:463985. [PMID: 22888337 DOI: 10.1155/2012/463985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
31 Hsu PI, Wu DC, Wu JY, Graham DY. Modified sequential Helicobacter pylori therapy: Proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter. 2011;16:139-145. [PMID: 21435092 DOI: 10.1111/j.1523-5378.2011.00828.x] [Cited by in Crossref: 122] [Cited by in F6Publishing: 124] [Article Influence: 11.1] [Reference Citation Analysis]
32 Hsu PI, Wu DC, Chen A, Peng NJ, Tseng HH, Tsay FW, Lo GH, Lu CY, Yu FJ, Lai KH. Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures. Eur J Clin Invest. 2008;38:404-409. [PMID: 18435764 DOI: 10.1111/j.1365-2362.2008.01951.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
33 Hsu PI, Lai KH, Tseng HH, Lo GH, Lo CC, Lin CK, Cheng JS, Chan HH, Ku MK, Peng NJ. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Aliment Pharmacol Ther. 2001;15:195-201. [PMID: 11148437 DOI: 10.1046/j.1365-2036.2001.00903.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 3.1] [Reference Citation Analysis]
34 Vollaard AM, Verspaget HW, Ali S, Visser LG, Veenendaal RA, Van Asten HA, Widjaja S, Surjadi Ch, Van Dissel JT. Helicobacter pylori infection and typhoid fever in Jakarta, Indonesia. Epidemiol Infect 2006;134:163-70. [PMID: 16409664 DOI: 10.1017/S0950268805004875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
35 Chen TS, Li FY, Chang FY, Lee SD. Immunoglobulin G antibody against Helicobacter pylori: clinical implications of levels found in serum. Clin Diagn Lab Immunol 2002;9:1044-8. [PMID: 12204957 DOI: 10.1128/cdli.9.5.1044-1048.2002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
36 Gong EJ, Lee JY, Bae SE, Park YS, Choi KD, Song HJ, Lee GH, Jung HY, Jeong WJ, Cheon GJ, Yook JH, Kim BS. Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology.PLoS One. 2018;13:e0195264. [PMID: 29621300 DOI: 10.1371/journal.pone.0195264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
37 Wu DC, Hsu PI, Tseng HH, Tsay FW, Lai KH, Kuo CH, Wang SW, Chen A. Helicobacter pylori infection: a randomized, controlled study comparing 2 rescue therapies after failure of standard triple therapies. Medicine (Baltimore). 2011;90:180-185. [PMID: 21512411 DOI: 10.1097/md.0b013e31821c9d1c] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
38 Hsu PI, Lai KH, Wu CJ, Tseng HH, Tsay FW, Peng NJ, Chen TA, Chuah SK, Lin WS, Lo GH. High-dose versus low-dose esomeprazole-based triple therapy for Helicobacter pylori infection. Eur J Clin Invest. 2007;37:724-730. [PMID: 17696962 DOI: 10.1111/j.1365-2362.2007.01852.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]